Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial

Infections lead to substantial morbidity during the treatment of acute lymphoblastic leukemia (ALL) in which the adaptive immune system is severely affected, leading to declining serum immunoglobulin levels. We performed a trial to investigate whether intravenous immunoglobulin (IVIG) prophylaxis in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Thus, Kirsten A. (VerfasserIn) , Groot-Kruseman, Hester A. de (VerfasserIn) , Winkler-Seinstra, Pauline (VerfasserIn) , Fiocco, Marta (VerfasserIn) , Segers, Heidi (VerfasserIn) , Bos, Cor van den (VerfasserIn) , Sluis, Inge M. van der (VerfasserIn) , Tissing, Wim J. E. (VerfasserIn) , Veening, Margreet A. (VerfasserIn) , Zwaan, Christian Michel (VerfasserIn) , Tilburg, Cornelis M. van (VerfasserIn) , Pieters, Rob (VerfasserIn) , Bierings, Marc (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: January, 2025
In: Haematologica
Year: 2025, Jahrgang: 110, Heft: 1, Pages: 47-54
ISSN:1592-8721
DOI:10.3324/haematol.2024.285428
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3324/haematol.2024.285428
Verlag, kostenfrei, Volltext: https://haematologica.org/article/view/haematol.2024.285428
Volltext
Verfasserangaben:Kirsten A. Thus, Hester A. de Groot-Kruseman, Pauline Winkler-Seinstra, Marta Fiocco, Heidi Segers, Cor van den Bos, Inge M. van der Sluis, Wim J. E. Tissing, Margreet A. Veening, Christian Michel Zwaan, Cornelis M. van Tilburg, Rob Pieters, Marc Bierings

MARC

LEADER 00000naa a2200000 c 4500
001 1949709620
003 DE-627
005 20260120120835.0
007 cr uuu---uuuuu
008 260120s2025 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2024.285428  |2 doi 
035 |a (DE-627)1949709620 
035 |a (DE-599)KXP1949709620 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Thus, Kirsten A.  |e VerfasserIn  |0 (DE-588)1387244124  |0 (DE-627)1949732193  |4 aut 
245 1 0 |a Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia  |b results of a multicenter randomized trial  |c Kirsten A. Thus, Hester A. de Groot-Kruseman, Pauline Winkler-Seinstra, Marta Fiocco, Heidi Segers, Cor van den Bos, Inge M. van der Sluis, Wim J. E. Tissing, Margreet A. Veening, Christian Michel Zwaan, Cornelis M. van Tilburg, Rob Pieters, Marc Bierings 
264 1 |c January, 2025 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 20.01.2026 
500 |a Zuerst veröffentlicht 8. August 2024 
520 |a Infections lead to substantial morbidity during the treatment of acute lymphoblastic leukemia (ALL) in which the adaptive immune system is severely affected, leading to declining serum immunoglobulin levels. We performed a trial to investigate whether intravenous immunoglobulin (IVIG) prophylaxis in pediatric patients with ALL could prevent admissions for fever. This randomized controlled trial was a subtrial of the national Dutch multicenter ALL study. Patients aged 1-19 years with medium-risk ALL were randomized into two groups receiving either IVIG prophylaxis (0.7 g/kg IVIG given every 3 weeks, starting on day 22 after diagnosis) or well-defined standard of care (control group). Between October 2012 and March 2019, 91 (51%) patients were randomly assigned to IVIG prophylaxis and 86 (49%) to the control arm. In the IVIG prophylaxis group there were 206 admissions for fever versus 271 in the control group (P=0.011). IVIG prophylaxis was not associated with bacteremia. However, there were significantly fewer admissions for fever with negative blood cultures in the IVIG prophylaxis group than in the control group (113 vs. 200, P<0.001). The difference in number of admissions for fever was observed specifically during maintenance treatment (100 vs. 166, P<0.001) resulting in fewer courses of antibiotic treatment (78 vs. 137, P<0.001) and fewer cases of chemotherapy adaptation (72 vs. 134, P<0.001). In conclusion, in pediatric patients with medium-risk ALL, IVIG prophylaxis was associated with significantly fewer admissions for fever with negative blood cultures during maintenance treatment, resulting in fewer courses of antibiotic treatment and fewer chemotherapy adaptations. 
700 1 |a Groot-Kruseman, Hester A. de  |e VerfasserIn  |4 aut 
700 1 |a Winkler-Seinstra, Pauline  |e VerfasserIn  |4 aut 
700 1 |a Fiocco, Marta  |e VerfasserIn  |4 aut 
700 1 |a Segers, Heidi  |e VerfasserIn  |4 aut 
700 1 |a Bos, Cor van den  |e VerfasserIn  |4 aut 
700 1 |a Sluis, Inge M. van der  |e VerfasserIn  |4 aut 
700 1 |a Tissing, Wim J. E.  |e VerfasserIn  |4 aut 
700 1 |a Veening, Margreet A.  |e VerfasserIn  |4 aut 
700 1 |a Zwaan, Christian Michel  |e VerfasserIn  |4 aut 
700 1 |a Tilburg, Cornelis M. van  |e VerfasserIn  |0 (DE-588)1144664527  |0 (DE-627)1004962355  |0 (DE-576)495479519  |4 aut 
700 1 |a Pieters, Rob  |e VerfasserIn  |4 aut 
700 1 |a Bierings, Marc  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Found, 1996  |g 110(2025), 1, Seite 47-54  |h Online-Ressource  |w (DE-627)32474224X  |w (DE-600)2030158-3  |w (DE-576)281198683  |x 1592-8721  |7 nnas  |a Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia results of a multicenter randomized trial 
773 1 8 |g volume:110  |g year:2025  |g number:1  |g pages:47-54  |g extent:8  |a Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia results of a multicenter randomized trial 
856 4 0 |u https://doi.org/10.3324/haematol.2024.285428  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://haematologica.org/article/view/haematol.2024.285428  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20260120 
993 |a Article 
994 |a 2025 
998 |g 1144664527  |a Tilburg, Cornelis M. van  |m 1144664527:Tilburg, Cornelis M. van  |d 910000  |d 910500  |e 910000PT1144664527  |e 910500PT1144664527  |k 0/910000/  |k 1/910000/910500/  |p 11 
999 |a KXP-PPN1949709620  |e 4855133817 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 20.01.2026","Zuerst veröffentlicht 8. August 2024"],"person":[{"roleDisplay":"VerfasserIn","family":"Thus","role":"aut","display":"Thus, Kirsten A.","given":"Kirsten A."},{"family":"Groot-Kruseman","roleDisplay":"VerfasserIn","given":"Hester A. de","display":"Groot-Kruseman, Hester A. de","role":"aut"},{"given":"Pauline","role":"aut","display":"Winkler-Seinstra, Pauline","roleDisplay":"VerfasserIn","family":"Winkler-Seinstra"},{"role":"aut","display":"Fiocco, Marta","given":"Marta","family":"Fiocco","roleDisplay":"VerfasserIn"},{"family":"Segers","roleDisplay":"VerfasserIn","given":"Heidi","role":"aut","display":"Segers, Heidi"},{"family":"Bos","roleDisplay":"VerfasserIn","display":"Bos, Cor van den","role":"aut","given":"Cor van den"},{"family":"Sluis","roleDisplay":"VerfasserIn","role":"aut","display":"Sluis, Inge M. van der","given":"Inge M. van der"},{"roleDisplay":"VerfasserIn","family":"Tissing","role":"aut","display":"Tissing, Wim J. E.","given":"Wim J. E."},{"given":"Margreet A.","display":"Veening, Margreet A.","role":"aut","family":"Veening","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Zwaan","given":"Christian Michel","display":"Zwaan, Christian Michel","role":"aut"},{"display":"Tilburg, Cornelis M. van","role":"aut","given":"Cornelis M. van","roleDisplay":"VerfasserIn","family":"Tilburg"},{"given":"Rob","display":"Pieters, Rob","role":"aut","family":"Pieters","roleDisplay":"VerfasserIn"},{"family":"Bierings","roleDisplay":"VerfasserIn","given":"Marc","role":"aut","display":"Bierings, Marc"}],"physDesc":[{"extent":"8 S."}],"id":{"doi":["10.3324/haematol.2024.285428"],"eki":["1949709620"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 22.10.07"],"origin":[{"publisherPlace":"Pavia","dateIssuedDisp":"1996-2004","dateIssuedKey":"1996","publisher":"Ferrata Storti Found"}],"id":{"zdb":["2030158-3"],"issn":["1592-8721"],"eki":["32474224X"]},"recId":"32474224X","title":[{"title_sort":"Haematologica","subtitle":"journal of hematology ; official organ for The Italian Society of Hematology, The Italian Society of Experimental Hematology, The Spanish Association of Hematology and Hemotherapy, The Italian Society of Hemostasis and Thrombosis, and The Italian Society of Pediatric, Hematology, Oncology","title":"Haematologica"}],"disp":"Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia results of a multicenter randomized trialHaematologica","name":{"displayForm":["founded by Adolfo Ferrata"]},"part":{"volume":"110","issue":"1","extent":"8","pages":"47-54","text":"110(2025), 1, Seite 47-54","year":"2025"},"pubHistory":["Nachgewiesen 79.1994 - 89.2004"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"January, 2025"}],"title":[{"subtitle":"results of a multicenter randomized trial","title_sort":"Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia","title":"Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia"}],"recId":"1949709620","language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Kirsten A. Thus, Hester A. de Groot-Kruseman, Pauline Winkler-Seinstra, Marta Fiocco, Heidi Segers, Cor van den Bos, Inge M. van der Sluis, Wim J. E. Tissing, Margreet A. Veening, Christian Michel Zwaan, Cornelis M. van Tilburg, Rob Pieters, Marc Bierings"]}} 
SRT |a THUSKIRSTEIMMUNOGLOB2025